Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Blood cultures are limited for diagnosing invasive candidiasis by poor sensitivity and slow turn-around time. New diagnostics are needed to complement cultures, in particular to identify the "missing 50%" of patients who are blood culture-negative. Mannan/anti-mannan immunoglobulin G, β-D-glucan (BDG) and polymerase chain reaction (PCR) assays can diagnose candidemia before blood cultures and show promising sensitivity/specificity, but they are not widely investigated in blood culture-negative, deep-seated candidiasis. In a recent study, BDG and PCR were superior to blood cultures in deep-seated candidiasis, suggesting they may identify currently undiagnosed patients and expand our understanding of disease spectrum. Positive predictive values of nonculture tests are limited by the low prevalence of invasive candidiasis, which mandates that results be interpreted judiciously. When used as biomarkers that assess a patient's risk of having invasive candidiasis, tests will facilitate preemptive antifungal strategies. Because negative predictive values are excellent, tests will also be useful for ruling out invasive candidiasis and discontinuing unnecessary antifungal therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blood cultures, however, are positive in only 21–71% of patients later proven by autopsy to have IC.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“In concert, this data has led to the conclusion that the sensitivity for blood cultures for invasive candidiasis is only 50%.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“However, blood cultures cannot be relied upon in all cases of IC given approximately one-third of patients with IC are categorized as having deep-seated infection without candidemia.16”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [16]
In the citing paper
“Previous studies of autopsy-proven invasive candidiasis suggest that blood cultures are positive in 21%-71% of cases [9], which suggests that the estimated burden of invasive candidiasis would be even higher, although further evaluation of the relative burden of candidemia in overall invasive candidiasis is needed.”
From Burden of Candidemia in the United States, 2017 (2020) · cites this paper as [9]
In the citing paper
“StC events could have been missed because of missed screening opportunities, the insensitivity of culture (9), treating clinical laboratories that might not routinely distinguish C. auris from other Candida species for nonsterile specimen types (10), and the fact that US C. auris data from 2024 are not finalized, meaning some patients might not have had sufficient lead time for clinical cases to”
From Progression from Candida auris Colonization Screening to Clinical Case Status, United States, 2016–2023 (2025) · cites this paper as [9]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758
Self-citation-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis
Karageorgopoulos, D. E., Vouloumanou, E. K., Ntziora, F., Michalopoulos, A., Rafailidis, P. I., & Falagas, M. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq206 · Cited by 538
Leroy, O., Gangneux, J.-P., Montravers, P., Mira, J.-P., Gouin, F., Sollet, J.-P., Carlet, J., Reynes, J., Rosenheim, M., Regnier, B., et al. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819efac0 · Cited by 535
Hepatic Candidiasis in Cancer Patients: The Evolving Picture of the Syndrome
THALER, M., PASTAKIA, B., SHAWKER, T. H., O'LEARY, T., & PIZZO, P. A. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-88 · Cited by 395
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
Avni, T., Leibovici, L., & Paul, M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01602-10 · Cited by 389
Ostrosky-Zeichner, L., Sable, C., Sobel, J., Alexander, B. D., Donowitz, G., Kan, V., Kauffman, C. A., Kett, D., Larsen, R. A., Morrison, V., et al. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0270-z · Cited by 369
Mikulska, M., Calandra, T., Sanguinetti, M., Poulain, D., Viscoli, C., & the Third European Conference on Infections in Leukemia Group (2010) · Critical Care · doi:10.1186/cc9365 · Cited by 319 · cited 2×
“Values for the combined assay were 83% and 86%, with best performances for C. albicans , C. glab-rata , and Candida tropicalis infections [17].”
Result
Research works printed but not linked: 1
- Nguyen MH Clancy CJ . Washington, DC: American Society for Microbiology; 2012. Intra-abdominal candidiasis (IAC) Is under-recognized, but is the most common yype of invasive candidiasis (IC) and results in poor outcomes [abstract M1685]; p. 164. Program and abstracts of the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco.
Cited by
Items 201–300 of 688
Carugati, M., Morlacchi, L. C., Peri, A. M., Alagna, L., Rossetti, V., Bandera, A., Gori, A., Blasi, F., & on behalf of the IFALT Working Group (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041221 · Cited by 23
“Unfortunately, Candida blood culture sensitivity is well known to be <60%, making the diagnosis of Candida invasive infections troublesome [14].”
BackgroundPoissy, J., Rouzé, A., Cornu, M., Nseir, S., & Sendid, B. (2022) · Journal of Fungi · doi:10.3390/jof8090946 · Cited by 25
“The main limitation of studies evaluating epidemiology and risk factors is that they focus mainly on candidemia and may miss up to 50% of cases of IC due to negative blood cultures [11], as reported in old autopsy studies [12].”
ResultProgress in the Diagnosis of Invasive Fungal Disease in Children
Warris, A., & Lehrnbecher, T. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0274-9 · Cited by 24
Decker, S., Krüger, A., Wilk, H., Grumaz, S., Vainshtein, Y., Schmitt, F. C. F., Uhle, F., Bruckner, T. M., Zimmermann, S., Mehrabi, A., et al. (2019) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-019-01769-y · Cited by 23
Antoran, A., Aparicio-Fernandez, L., Pellón, A., Buldain, I., Martin–Souto, L., Rementería, A., Ghannoum, M. A., Fuchs, B. B., Mylonakis, E. E., Hernando, F. L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-65859-4 · Cited by 23
Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?
Vázquez, J. A., Whitaker, L., & Zubovskaia, A. (2025) · Journal of Fungi · doi:10.3390/jof11040258 · Cited by 32
“On the other hand, patients with deep-seated candidiasis, most commonly in the setting of intra-abdominal perforation, rarely have positive blood cultures [32,33].”
InfluentialShen, H., Yu, Y., Chen, S.-M., Sun, J., Fang, W. Y., Guo, S., Hou, W.-T., Qiu, X.-R., Zhang, Y., Chen, Y., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01648 · Cited by 24
“risk factors, such as immunocompromise, have been established for IC (Clancy and Nguyen, 2013; Candel et al., 2017).”
BackgroundJaffal, K., Poissy, J., Rouzé, A., Préau, S., Sendid, B., Cornu, M., & Nseir, S. (2018) · Annals of Intensive Care · doi:10.1186/s13613-018-0392-8 · Cited by 25
“Clinical signs of invasive Candida infection are nonspecific, risk factors are common, the predictive positive value of all scores set to help clinicians remains insufficient [8, 9], and blood cultures have insufficient diagnostic accuracy [10, 11].”
BackgroundSchroeder, J. A., Wilson, C. M., & Pappas, P. G. (2024) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2024.11.007 · Cited by 31
Candidemia Diagnosed from Peripheral Blood Smear: Case Report and Review of Literature 1954–2013
Hirai, Y., Asahata, S., Ainoda, Y., Fujita, T., Miura, H., Hizuka, N., & Kikuchi, K. (2015) · Mycopathologia · doi:10.1007/s11046-015-9884-3 · Cited by 21
“culture remains the ‘gold standard’ diagnostic procedure in candidaemia, test sensitivity in patients with febrile neutropenia ranged from 25 to 71 % in autopsy studies [36].”
BackgroundHepatosplenic Candidiasis Without Prior Documented Candidemia: An Underrecognized Diagnosis?
van Prehn, J., van Oordt, C. W. M. D. H., de Rooij, M. L., Meijer, E., Bomers, M. K., & van Dijk, K. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0019 · Cited by 23
“Deep-seated infections may remain localized without positive blood cultures [9].”
BackgroundBeyda, N. D., Amadio, J., Rodriguez, J. R., Malinowski, K., Garey, K. W., Wanger, A. R., & Ostrosky-Zeichner, L. L. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00471-18 · Cited by 24
“Blood culture is the gold standard method for the diagnosis of candidemia, despite a sensitivity of 50% and a median time to detection (TTD) ranging from 2 days to 3 days or longer depending on the Candida species (3).”
BackgroundSerological biomarkers of candidemia: a retrospective evaluation of three assays
Dichtl, K., Seybold, U., & Wagener, J. (2018) · Infection · doi:10.1007/s15010-018-1224-3 · Cited by 22
Nieto, M., Robles, J. C., Causse, M., Gutiérrez, L., Perez, M. C., Ferrer, R., Xercavins, M., Herrero, E., Sirvent, E., Fernández, C., et al. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0248-z · Cited by 24
Comparative sensitivity of 1,3 beta‐D‐glucan for common causes of candidaemia in South Africa
Chibabhai, V., Fadana, V., Bosman, N., & Nana, T. (2019) · Mycoses · doi:10.1111/myc.12982 · Cited by 23
Krylov, V. B., Solovev, A. S., Puchkin, I. A., Yashunsky, D. V., Antonets, A. V., Kutsevalova, O. Y., & Nifantiev, N. E. (2021) · Journal of Fungi · doi:10.3390/jof7070504 · Cited by 23
“The IC diagnosis is still difficult due to the lack of specificity of the clinical symptoms and poor sensitivity of the cultural methods on blood samples up to only ~50% [3,4].”
BackgroundRecent advances in the treatment of life-threatening, invasive fungal infections
Drew, R. H., Townsend, M. L., Pound, M. W., Johnson, S. W., & Perfect, J. R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.838217 · Cited by 31
“For example, studies in several different patient populations with a variety of IFIs have demonstrated that blood and/or tissue cultures are often positive in < 50% of patients with proven IFIs [11].”
BackgroundGold, J. A. W., Seagle, E. E., Nadle, J., Barter, D. M., Czaja, C. A., Johnston, H., Farley, M. M., Thomas, S., Harrison, L. H., Fischer, J., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab512 · Cited by 20
“Because it generally takes at least 2–4 days after blood culture collection to detect and identify Candida species, and because access to AFST may be limited or delayed, clinicians usually select initial antifungal treatment based on local species epidemiology, antifungal resistance patterns, and individual patient fa…”
BackgroundYeoh, S. F., Lee, T. J., Chew, K. L., Lin, S., Yeo, D., & Setia, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s165676 · Cited by 20
“They may still lack sensitivity, specificity or both, and are unable to differentiate between active infection and inactive/dormant stage of microbes.(77) The aforementioned disadvantages of currently available invasive and non-invasive diagnostic tools principally contribute to a delay in diagnosis.”
BackgroundResultMachine learning to identify clinically relevant Candida yeast species
Shankarnarayan, S. A., & Charlebois, D. A. (2023) · Medical Mycology · doi:10.1093/mmy/myad134 · Cited by 30
The Molecular Diagnosis of Invasive Fungal Diseases with a Focus on PCR
Brown, L., Cruciani, M., Morton, C. O., Alanio, A., Barnes, R. A., Donnelly, J. P., Hagen, F., Gorton, R., Lackner, M., Loeffler, J., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15151909 · Cited by 26
“The diagnosis of invasive candidiasis (IC) largely relies on blood culture which, if positive, provides the advantage of speciation and susceptibility testing, though sensitivity is low (21–71% across the spectrum of IC +/ − candidemia) and TAT is at least 2 to 3 days [5,48,49].”
Cento, V., Alteri, C., Mancini, V., Gatti, M., Lepera, V., Mazza, E., Moioli, M. C., Merli, M., Colombo, J., Orcese, C. A., et al. (2020) · Mycoses · doi:10.1111/myc.13170 · Cited by 22
Lee, A., Wang, N., Carter, C. L., Zimmerman, M., Dartois, V. A., Shaw, K. J., Perlin, D. S., & Zhao, Y. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02476-20 · Cited by 21
Soltani, S., Zandi, M., Faramarzi, S., Shahbahrami, R., Vali, M., Rezayat, S. A., Pakzad, R., Malekifar, P., Pakzad, I., Jahandoost, N., et al. (2022) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2021.0293 · Cited by 24
Screening for Ocular Candidiasis Among Patients With Candidemia: Is It Time to Change Practice?
O’Donnell, M., Eller, A. W., Waxman, E. L., Clancy, C. J., & Nguyen, M. H. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac233 · Cited by 21
Self-citationSevere Candida infections in critically ill patients with COVID-19
Koulenti, D., Karvouniaris, M., Paramythiotou, E., Koliakos, N. N., Μάρκου, Ν., Paranos, P., Meletiadis, J., & Blot, S. I. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.07.005 · Cited by 26
“[ 6 ] The basic culture media for clinical Candida species is usually Sabouraud dextrose agar or broth supplemented with chloramphenicol and blood agar.”
BackgroundChen, Y., Wang, J., & Niu, T. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09073-x · Cited by 23
“However, traditional methods such as blood culture are limited by their low throughput, narrow coverage of pathogen spectrum and time consumption, which has led to the irrational use of antibiotics [6].”
BackgroundLiu, Y., Chen, F., Zhu, X., Shen, L., & Zhang, S. X. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.00673-15 · Cited by 20
“It is true that the sensitivity of a blood culture in detecting candidemia is not high (7), but none of these patients presented with evidence of fungal infections.”
BackgroundT2Candida magnetic resonance in patients with invasive candidiasis: Strengths and limitations
Zurl, C., Prattes, J., Zollner‐Schwetz, I., Valentin, T., Rabensteiner, J., Wunsch, S., Hoenigl, M., & Krause, R. (2019) · Medical Mycology · doi:10.1093/mmy/myz101 · Cited by 23
Performance of a new Candida anti-mannan IgM and IgG assays in the diagnosis of candidemia
Meng, Y., Kang, M., Li, D., Wang, T., Kuang, Z., & Ma, Y. (2020) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202062025 · Cited by 21
Invasive fungal infections following liver transplantation
Hogen, R., & Dhanireddy, K. K. (2017) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000431 · Cited by 20
Ito‐Takeichi, S., Niwa, T., Fujibayashi, A., Suzuki, K., Ohta, H., Niwa, A., Tsuchiya, M., Yamamoto, M., Hatakeyama, D., Suzuki, A., et al. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12809 · Cited by 22
“699c Charlson comorbidity index, median (interquartile range) 7 (0‐13) 7 (2-14) 0.”
InfluentialMeneghello, S., Bernabé, G., Pietra, G. D., Sopra, S. D., Vecchio, C. D., Cattelan, A. M., Castagliuolo, I., & Brun, P. (2024) · Journal of Fungi · doi:10.3390/jof10100707 · Cited by 25
“Early diagnosis is challenging in children because of the nonspecific symptoms of candidemia and low sensitivity of blood cultures [26].”
BackgroundGuo, Y., Yang, J.-X., & Liang, G. (2015) · Mycopathologia · doi:10.1007/s11046-015-9977-z · Cited by 19
Bomkamp, J. P., Sulaiman, R., Hartwell, J. L., Desai, A., Winn, V., Wrin, J. E., Kussin, M. L., & Hiles, J. J. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01408-19 · Cited by 19
“Studies have shown that the sensitivity of blood culture for the detection of candidemia is approximately 50% (4).”
BackgroundCutaneous fungal infections in solid organ transplant recipients
Ilyas, M., & Sharma, A. (2017) · Transplantation Reviews · doi:10.1016/j.trre.2017.03.001 · Cited by 22
Guo, J., Wu, Y., Lai, W., Lu, W., & Mu, X. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4364-x · Cited by 19
Mikulska, M., Ullah, N., Magnasco, L., Codda, G., Bartalucci, C., Miletich, F., Sepulcri, C., Willison, E., Vena, A., Giacobbe, D. R., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.02.012 · Cited by 20
Endogenous endophthalmitis: New insights from a 12-year cohort study
Dedieu, D., Contejean, A., Gastli, N., Reboul‐Marty, J., Poupet, H., Brézin, A. P., Monnet, D., Charlier, C., & Canouï, É. (2024) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2024.107116 · Cited by 18
Timsit, J., Azoulay, É., Cornet, M., Gangneux, J., Jullien, V., Vesin, A., Schir, É., & Wolff, M. (2013) · Trials · doi:10.1186/1745-6215-14-399 · Cited by 21
“However, (1–3)-βD-glucan is not specific of candidiasis, is higher than 80 pg/ml in many ICU patients without invasive candidiasis and decreases slowly under effective treatment [39-41].”
BackgroundMurri, R., Camici, M., Posteraro, B., Giovannenze, F., Taccari, F., Ventura, G., Scoppettuolo, G., Sanguinetti, M., Cauda, R., & Fantoni, M. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s181489 · Cited by 20
“The gold standard method for the diagnosis of Candida BSIs are blood cultures, which usually take about 2 days to yield positive results, but their sensitivity is as low as 50%.(5,6) Many studies have investigated the risk factors for candidemia; however, the list of risk factors is large(7) and most of the hospitaliz…”
MethodEmerging Microbiology Diagnostics for Transplant Infections: On the Cusp of a Paradigm Shift
Azar, M. M., Gaston, D. C., Kotton, C. N., & Malinis, M. F. (2020) · Transplantation · doi:10.1097/tp.0000000000003123 · Cited by 19
“Though still considered the current standard for detection of candidemia, blood cultures are only 50% sensitive for invasive candidiasis.(23) Direct detection of Candida spp.”
BackgroundSendid, B., Poissy, J., François, N., Méry, A., Courtecuisse, S., Krzewinski, F., Jawhara, S., Guérardel, Y., & Poulain, D. (2014) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.08.010 · Cited by 19
“In contrast to bacterial infections, blood cultures dramatically lack sensitivity (50%) [2].”
BackgroundRae, N., Kenny, C. C., & Muldoon, E. G. (2018) · Mycoses · doi:10.1111/myc.12874 · Cited by 19
“Obtaining a microbiological diagnosis in invasive candidosis can be difficult, with sensitivity of blood cultures being estimated at approximately 50% in patients with invasive candidiasis [40].”
BackgroundZeng, X., Jiang, Q., Yang, F., Wu, Q., lyu, T., Zhang, Q., Wang, J., Li, F., & Xu, D. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00268-25 · Cited by 17
“D - glucan testing (G - test) (6), and quantitative PCR (qPCR) assays (7), are used in some laboratories but have not been extensively evaluated in cases of deep-seated candidiasis with negative blood cultures (8).”
Christner, M., Abdennadher, B., Wichmann, D., Kluge, S., Pepić, A., Aepfelbacher, M., Rohde, H., & Olearo, F. (2023) · Infection · doi:10.1007/s15010-023-02053-4 · Cited by 21
“The gold standard histopathological detection of fungi in tissue specimens is often inapplicable [3] and the diagnostic value of routinely performed blood cultures [4] is reduced by low sensitivity and inherently slow turnaround times [5].”
Singh, A. K., Kaur, A., & Chowdhary, A. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2023.102365 · Cited by 21
Candida auris: A focused review for emergency clinicians
Long, B., Lacy, A. J., Koyfman, A., & Liang, S. Y. (2024) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2024.07.062 · Cited by 18
Fidler, G., Leiter, É., Kocsubé́, S., Bíró, S., & Paholcsek, M. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3283-6 · Cited by 19
“With regard to surrogate-marker based molecular methods, the antimannan antibody (Platelia GM-enzyme immunoassay, Bio-Rad) and 1,3-ß-D-glucan (BDG) antigen based (Fungitell assay, Associates of Cape Cod) immunological assays have good performances and may be useful in diagnosing of invasive fungal infections [30].”
MethodGiannella, M., Paolucci, M., Roncarati, G., Vandi, G., Pascale, R., Trapani, F., Bartoletti, M., Tedeschi, S., Ambretti, S., Lewis, R. E., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky247 · Cited by 17
Increased risk of candidemia in patients with necrotising pancreatitis infected with candida species
Rasch, S., Mayr, U., Phillip, V., Schmid, R. M., Huber, W., Algül, H., & Lahmer, T. (2018) · Pancreatology · doi:10.1016/j.pan.2018.07.005 · Cited by 18
Antifungal Clinical Trials and Guidelines: What We Know and Do Not Know
Pappas, P. G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019745 · Cited by 18
Is (1,3)-β-d-glucan useless to guide antifungal therapy in ICU?
Rouzé, A., Estella, Á., & Timsit, J. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06766-2 · Cited by 18
“Blood and sterile-site cultures, the current diagnostic gold standards, are limited by poor sensitivity and long delay to positivity [5].”
BackgroundSedik, S., Egger, M., Wolfgruber, S., Salmanton‐García, J., Bassetti, M., Mikulska, M., Özenci, V., Arıkan-Akdağlı, S., Akova, M., Gangneux, J., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106629 · Cited by 22
Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection—A Prospective Pilot Study
Koehler, F. C., Cornely, O. A., Wisplinghoff, H., Schauss, A. C., Salmanton‐García, J., Ostermann, H., Ziegler, M., Bächer, P., Scheffold, A., Alex, R., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01381 · Cited by 17
“Microscopy, histopathology, and culture of infectious tissue samples require surgery or other invasive procedures with significant risks for the patient, whereas the Candida-reactive lymphocyte assay is a non-invasive, peripheral blood test with little to no risks for the patient (Clancy and Nguyen, 2013).”
BackgroundThe Current State of Antifungal Stewardship in Immunocompromised Populations
Alegria, W., & Patel, P. (2021) · Journal of Fungi · doi:10.3390/jof7050352 · Cited by 17
Updates on the profile of GenMark’s ePlex blood culture identification fungal pathogen panel
Mizusawa, M., & Carroll, K. C. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2215929 · Cited by 19
“cultures for invasive candidiasis is only around 50% [11].”
BackgroundZito, A., Bromuro, C., Mandili, G., Chiani, P., Horenstein, A. L., Malavasi, F., Cauda, R., Cassone, A., & Torosantucci, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148714 · Cited by 16
“albicans and other Candida species are a major cause of morbidity and mortality in hospitalized patients worldwide [1,2].”
BackgroundMEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management
Scudeller, L., Bassetti, M., Concia, E., Corrao, S., Cristini, F., Rosa, F. G. D., Bono, V. D., Durante‐Mangoni, E., Falcone, M., Menichetti, F., et al. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.07.007 · Cited by 15
“Considering that up to 50% of IC diagnoses are estimated to be missed, attending physicians need a high index of suspicion to hasten microbiological diagnosis and manage these potentially severe infections [44].”
BackgroundQuirino, A., Scaglione, V., Marascio, N., Mazzitelli, M., Garofalo, E., Divenuto, F., Serapide, F., Bruni, A., Lionello, R., Pavia, G., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07096-w · Cited by 18
“The reported sensitivity rates of the T2Candida Panel range 89–100%, which are higher than that of standard BC for candidemia (50%) [20, 24, 25].”
BackgroundMarinelli, T. M., Pennington, K. M., Hamandi, B., Donahoe, L. L., Rotstein, C., Martinu, T., & Husain, S. (2022) · Transplant Infectious Disease · doi:10.1111/tid.13812 · Cited by 16
Ovchinsky, N., Frazier, W. J., Auletta, J. J., Dvorak, C. C., Ardura, M. I., Song, E., McArthur, J. A., Jeyapalan, A. S., Tamburro, R. F., Mahadeo, K. M., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.08.035 · Cited by 17
“Antifungal treatment should be initiated based on clinical suspicion, standard/institutional practice guidelines and local epidemiology (35, 58, 61-63).”
BackgroundElges, S., Arnold, R., Liesenfeld, O., Kofla, G., Mikołajewska, A., Schwartz, S., Uharek, L., & Ruhnke, M. (2017) · Mycoses · doi:10.1111/myc.12662 · Cited by 16
Culbreath, K., & Petti, C. A. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv075 · Cited by 17
“sensitivity of blood culture is excellent for detecting >95% of viable bacteria and some fungi circulating in blood [5, 6].”
BackgroundPfaller, M. A. (2015) · Journal of Fungi · doi:10.3390/jof1020217 · Cited by 19
Candidemia in the patient with malignancy
Alves, J., Palma, P., Azevedo, D., & Rello, J. (2018) · Hospital Practice · doi:10.1080/21548331.2018.1508290 · Cited by 19
“Positive detection in blood may indicate an invasive fungal infection, prior to positive blood cultures, although diagnostic performance was higher with two consecutive tests [28,33].”
BackgroundEstimated burden of fungal infections in Sweden
Özenci, V., Klingspor, L., Ullberg, M., Chryssanthou, E., Denning, D. W., & Kondori, N. (2019) · Mycoses · doi:10.1111/myc.12981 · Cited by 14
“19 Data on Cryptococcus meningitis were retrieved from all laborato‐ ries in Sweden.”
BackgroundFidel, P. L., Yano, J., Esher, S. K., & Noverr, M. C. (2020) · Journal of Fungi · doi:10.3390/jof6010035 · Cited by 21
“Blood cultures are both ineffective (over half of patients with HDC are blood culture negative) and time-intensive (median time to positivity is 2–3 days) [39,40].”
BackgroundSingh, S., Singh, M., Verma, N., Sharma, M., Pradhan, P., Chauhan, A., Jaiswal, N., Chakrabarti, A., & Singh, M. (2020) · Medical Mycology · doi:10.1093/mmy/myaa038 · Cited by 18
Detection of Candida albicans Using a Manufactured Electrochemical Sensor
Dutta, P., Lu, Y.-J., Hsieh, H., Lee, T.-Y., Lee, Y., Cheng, C., & Fan, Y. (2021) · Micromachines · doi:10.3390/mi12020166 · Cited by 18
Risk factors and outcomes of deep tissue Candida invasion in neonates with invasive candidiasis
Eisi, H., Ibraheem, S., Hisham, T., Al‐Harbi, A., Saidy, K., Ali, I. M., Nour, I., & Nasef, N. (2021) · Mycoses · doi:10.1111/myc.13395 · Cited by 15
Madhumitha, R., Ramasubramanian, V., Nambi, P., Kumar, D., & Thirunarayan, M. A. (2018) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_4_18 · Cited by 16
“Although blood culture is the gold standard for diagnosis of candidemia, it suffers from low sensitivity (50%) and longer turnaround time (2–4 days).[3] As blood cultures are insensitive and time‐consuming, diagnosis of IC is often based on clinical suspicion, candidal score, and Candida colonization index, none of wh…”
Bloos, F., Held, J., Schlattmann, P., Brillinger, N., Kurzai, O., Cornely, O. A., & Thomas-Rüddel, D. O. (2018) · Trials · doi:10.1186/s13063-018-2868-0 · Cited by 17
Diagnosis of Invasive Fungal Infections in Children
Seth, R. K., Xess, I., & Jana, M. (2019) · Indian Pediatrics · doi:10.1007/s13312-019-1505-7 · Cited by 17
Jung, I. Y., Jeong, S. J., Kim, Y. K., Kim, H. Y., Song, Y. G., Kim, J. M., & Choi, J. Y. (2020) · Medicine · doi:10.1097/md.0000000000019494 · Cited by 16
“For cases of deep-seated candidemia, blood culture positivity is estimated to be less than 50%.([24]) Considering the low sensitivity of culture positivity in deep-seated candidemia, we believe that this finding raises awareness for clinicians, by indicating that Candida species isolated from blood should never be con…”
BackgroundLi, J., Jin, Z., Li, J., Su, L.-Y., Wang, Y.-X., Zhang, Y., Qin, D., Rao, G.-X., & Wang, R. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114201 · Cited by 14
Seitz, T., Holbik, J., Hind, J., Gibas, G., Karolyi, M., Pawelka, E., Traugott, M. T., Wenisch, C., & Zoufaly, A. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00140-22 · Cited by 14
“Yet, this detection method has been shown to have a low sensitivity of 21%–71% for Candida species (9) and a sensitivity of 80%–96% for bacteria prior to initiation of antimicrobial therapy.”
BackgroundMethodBenedict, K., Gold, J. A. W., Jenkins, E. N., Roland, J., Barter, D., Czaja, C. A., Johnston, H. L., Clogher, P., Farley, M. M., Revis, A., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac461 · Cited by 14
O’Donnell, M., Shields, R. K., Marini, R. V., Groetzinger, L. M., Potoski, B. A., Falcione, B. A., Shah, S., McCreary, E. K., Clarke, L. G., Brant, E. B., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad538 · Cited by 15
“For T2Candida to be most useful to clinicians, a positive test should be associated with high enough probability of IC to warrant antifungal treatment, while a negative test should justify discontinuing treatment [3, 11].”
BackgroundSelf-citationA Narrative Review of Invasive Candidiasis in the Intensive Care Unit
Noppè, E., Eloff, J. R. P., Keane, S., & Martín‐Loeches, I. (2024) · Therapeutic Advances in Pulmonary and Critical Care Medicine · doi:10.1177/29768675241304684 · Cited by 21
Fungal Diseases in Taiwan—National Insurance Data and Estimation
Huang, Y., Denning, D. W., Shih, S.-M., Hsiung, C. A., Wu, U., Sun, H., Chen, P., Chen, Y., & Chang, S. (2019) · Journal of Fungi · doi:10.3390/jof5030078 · Cited by 16
Rapid diagnosis of invasive candidiasis: ready for prime-time?
Clancy, C. J., & Nguyen, M. H. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000594 · Cited by 17
“limited by slow turnaround and sensitivities of only 70 and 30% for candidemia and deep-seated candidiasis, respectively [3].”
BackgroundSelf-citationDiagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls
White, P. L. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000791 · Cited by 15
“Although no performance data specific for CAC is currently available, it is likely that blood culture sensitivity is comparable to that in nonCOVID-19 patients, detecting approximately 50% of all forms of IC, reduced when the organism causes deep-seated infection in the absence of fungaemia [43].”
BackgroundMaseda, E., Rodríguez, A. H., Aguilar, G., Pemán, J., Zaragoza, R., Ferrer, R., Llinares, P., & Grau, S. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.02.003 · Cited by 50
“9 Published studies confirm that the polymerase chain reaction and the (1 → 3)- (cid:2) -D- glucan quantification test are useful for the diagnosis of IC.”
Prophylactic Measures During Induction for Acute Myeloid Leukemia
McCarthy, M. W., & Walsh, T. J. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0574-9 · Cited by 15
Baronia, A. K., Sharma, P., Yadav, R., Marak, R. S. K., & Singh, R. K. (2017) · Indian Journal of Critical Care Medicine · doi:10.4103/ijccm.ijccm_33_17 · Cited by 16
“Early microbiological diagnosis of invasive candidiasis still remains a difficult issue.[2,3] Delay in the initiation of appropriate antifungal therapy is associated with increased mortality and morbidity.”
BackgroundEvaluation of host-based molecular markers for the early detection of human sepsis
Ullrich, E., Heidinger, P., Soh, J., Villanova, L., Grabuschnig, S., Bachler, T., Hirschböck, E., Sánchez-Heredero, S., Ford, B., Sensen, M., et al. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2020.01.013 · Cited by 14
Aşkun, T. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100869 · Cited by 16
An Estimate of the Burden of Fungal Disease in Norway
Nordøy, I., Hesstvedt, L., Andersen, C. T., Mylvaganam, H., Kols, N. I., Falch, B. M., Tofteland, S., Müller, F., & Denning, D. W. (2018) · Journal of Fungi · doi:10.3390/jof4010029 · Cited by 13
“Assuming that the laboratory-verified candidemia represent only 50% of the actual invasive Candida infections, we have doubled the number to make a more accurate estimate of the numbers [28].”
BackgroundEades, C. P., Bakri, A., Lau, J. C. Y., Moore, C. B., Frazer, L. N., Richardson, M. D., & Rautemaa‐Richardson, R. (2023) · Journal of Fungi · doi:10.3390/jof9080813 · Cited by 13
“Indeed, across multiple cohorts of fungaemic patients, an average sensitivity of 38% of has been reported in this setting [4].”
BackgroundInfluentialRinaldi, M., Bartoletti, M., Bonazzetti, C., Caroccia, N., Gatti, M., Tazza, B., Horna, C. S., Giannella, M., & Viale, P. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.106998 · Cited by 17
Prognostic value of serial (1,3)-β-d-glucan measurements in ICU patients with invasive candidiasis
Carelli, S., Posteraro, B., Torelli, R., Carolis, E. D., Vallecoccia, M. S., Xhemalaj, R., Cutuli, S. L., Tanzarella, E. S., Dell’Anna, A. M., Lombardi, G., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05022-x · Cited by 14
Choosing wisely: what is the actual role of antimicrobial stewardship in Intensive Care Units?
Montrucchio, G. G., Sales, G., Corcione, S., Rosa, F. G. D., & Brazzi, L. (2019) · Minerva Anestesiologica · doi:10.23736/s0375-9393.18.12662-9 · Cited by 15
A novel enzyme immunoassay for the measurement of plasma (1 → 3)-β-D-glucan levels
Sunamura, E.-I., Iwasaki, M., Shiina, S., Kitahara, S.-I., Yotani, T., Manabe, M., & Miyazaki, O. (2020) · Journal of Immunological Methods · doi:10.1016/j.jim.2020.112872 · Cited by 13
Use of T2MR in Invasive Candidiasis with and Without Candidemia
Zacharioudakis, I. M., Zervou, F. N., & Mylonakis, E. E. (2018) · Future Microbiology · doi:10.2217/fmb-2018-0079 · Cited by 13
Camp, I., Füszl, A., Selitsch, B., Kröckel, I., Kovac, K., Wahrmann, M., Steinlechner, B., Weber, J., Schellongowski, P., Zauner, C., et al. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.02.024 · Cited by 12
Recent Challenges in Diagnosis and Treatment of Invasive Candidiasis in Neonates
Baltogianni, M. S., Giapros, V. I., & Dermitzaki, N. (2024) · Children · doi:10.3390/children11101207 · Cited by 20
“Even with a sufficient volume of blood cultures, the overall sensitivity in diagnosing IC is estimated to be below 50% [9,70,80].”
BackgroundClancy, C. J., Shields, R. K., & Nguyen, M. H. (2016) · Journal of Fungi · doi:10.3390/jof2010010 · Cited by 13
“Candidemia and intra-abdominal candidiasis are believed to occur with equal frequency [4,9].”
BackgroundInfluentialSelf-citationDiagnostic Methods for Detection of Blood-Borne Candidiasis
Clancy, C. J., & Nguyen, M. H. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3052-4_16 · Cited by 13
Self-citationConclusion and future perspectives on antifungal stewardship
Aguado, J. M., Silva, J. T., & Bouza, E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw396 · Cited by 13
Metadata
- Authors
- Clancy, C. J., & Nguyen, M. H.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Clancy, Cornelius J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-11
- Volume
- 56
- Issue
- 9
- Pages
- 1284-1292
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2113002556
- Semantic Scholar
- 09ab621e4fddac8144b07f459f06bc7901d0d1bd
- Cited by
- 688
- References
- 39
- Citations by year
- 2026: 36 · 2025: 56 · 2024: 55 · 2023: 60 · 2022: 59 · 2021: 68 · 2020: 56 · 2019: 66 · 2018: 60 · 2017: 54 · 2016: 52 · 2015: 32 · 2014: 26 · 2013: 8
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- invasive candidiasis, beta-D-glucan assay, sensitivity and specificity, positive predictive value, negative predictive value, antifungal therapy, disease spectrum, biomarkers
- MeSH terms
- DNA, Fungal, Patient Care, Humans, Predictive Value of Tests, Sensitivity and Specificity, Biomarkers, Clinical Laboratory Techniques, beta-Glucans, Candidiasis, Invasive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.